OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Johnson and Johnson/  US4781601046  /

NYSE
6/13/2024  10:10:00 PM Chg. +0.04 Volume Bid12:09:13 PM Ask12:09:13 PM Market Capitalization Dividend Y. P/E Ratio
145.45USD +0.03% 6.84 mill.
Turnover: 563.95 mill.		 145.04Bid Size: 100 145.76Ask Size: 100 350.05 bill.USD 3.23% 10.48
GlobeNewswire 5/28 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
TeleTrader 5/1 J&J to pay $6.5 billion to settle US talc-related lawsuits
GlobeNewswire 4/17 TRC Amends Its Tender Offer for Johnson & Johnson
GlobeNewswire 4/10 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...
TeleTrader 4/5 J&J to acquire Shockwave Medical for $13.1B
TeleTrader 3/26 J&J may allegedly acquire Shockwave Medical
GlobeNewswire 3/15 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
GlobeNewswire 3/6 Ambrx Shareholders Approve Acquisition by Johnson & Johnson
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 1/24 J&J to pay $149.5M to settle Washington state opioid case
TeleTrader 1/23 J&J to pay $700M in talc powder probe settlement
TeleTrader 1/23 J&J's Q4 sales top estimates, up 7.3% to $21.4B
TeleTrader 1/23 Johnson & Johnson Q4 earnings preview
TeleTrader 1/22 Earnings preview: Tesla takes center stage
TeleTrader 1/8 J&J to buy biotech company Ambrx for $2B
GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...
TeleTrader 11/7/2023 J&J to begin trials with surgical robot
TeleTrader 10/17/2023 J&J's Q3 sales up 6.8% to $21.4 billion
TeleTrader 10/3/2023 J&J's $223.8M talc powder case fine overturned
TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate
TeleTrader 7/20/2023 J&J highest since January as Q2 results top estimates
TeleTrader 7/20/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion
TeleTrader 7/18/2023 J&J joins drug price suits against US gov't
TeleTrader 5/4/2023 J&J's Kenvue reportedly valued at $41B for IPO